When The Mirror Is Wrong
1 other identifier
interventional
16
1 country
1
Brief Summary
Body Dysmorphic Disorder (BDD) is a severe psychiatric condition characterized by persistent and intrusive preoccupations with perceived flaws in physical appearance, which are typically unnoticeable or appear minor to others. BDD is associated with significant psychological distress, functional impairment, and reduced quality of life. Despite its prevalence and clinical severity, BDD remains frequently underdiagnosed and misdiagnosed. While Cognitive Behavioural Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs) are currently considered standard treatments, emerging evidence suggests that third-wave psychotherapies, such as Acceptance and Commitment Therapy (ACT) and Compassion-Focused Interventions, may offer additional benefits. This project aims to advance clinical care and scientific understanding of BDD by developing, implementing, and evaluating the preliminary efficacy of MIND-over-MIRROR-a novel group-based psychological intervention integrating ACT and compassion-based strategies for individuals exhibiting high levels of BDD symptomatology. The intervention consists of eight weekly sessions and one follow-up booster session, delivered in an online or hybrid format. A randomized feasibility study will be conducted to examine the intervention's acceptability, practicality, and preliminary clinical efficacy in adults aged 18 to 65 years. A multi-method assessment framework will be employed, with self-report measures collected at baseline, post-intervention, and 3-month follow-up. Additionally, participants from experimental and control groups will report on their weekly BDD symptomatology. Participants in the intervention group who consent will also undergo computerized behavioural tasks and functional neuroimaging using functional near-infrared spectroscopy (fNIRS) to explore neural and cognitive correlates of treatment outcomes. Improvements are expected in core clinical outcomes, including BDD symptom severity, and it is hypothesized that changes in targeted psychological processes (e.g., self-compassion) will mediate these effects. This study will contribute novel and clinically relevant data regarding the feasibility and potential effectiveness of contextual behavioural therapies for BDD, with implications for both research and practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2025
CompletedFirst Submitted
Initial submission to the registry
June 16, 2025
CompletedFirst Posted
Study publicly available on registry
June 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedJune 29, 2025
June 1, 2025
1 year
June 16, 2025
June 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Appearance Anxiety Inventory
The Appearance Anxiety Inventory (AAI) is a brief 10 item self-report scale that assesses the cognitive and behavioral aspects of BDD in particular. This scale was specifically developed by the original authors as both an outcome and process measure, since it can track changes in these processes and behaviors during treatment. Besides its global score, the AAI includes three subscales: threat monitoring, camouflaging, and avoidance. Each item is scored on a 4-point scale ranging from not at all (0) to much more than most people (3). A score equal or above 21 is considered high risk body image anxiety and/or Body Dysmorphic Disorder.
Baseline, Weeks 1-8, 3-month follow-up
Dysmorphic Concern Questionnaire
The DCQ measures a person's degree of dysmorphic concern (i.e., the excessive preoccupation or concern with a perceived minor defect in one's physical appearance). This is a self-report measure with seven items, reporting on cognitive and behavioural aspects of dysmorphic concern. Each item is phrased with the question, "Have you ever…?" (e.g., "…been very concerned about some aspect of your physical appearance"). Each item is scored on a 4-point scale ranging from not at all (0) to much more than most people (3).
Baseline, Week 8, 3-month follow-up
Secondary Outcomes (5)
Patient Health Questionnaire - 9
Baseline, Week 8, 3-month follow-up
Change in the Multidimensional Psychological Flexibility Inventory - 24
Baseline, Week 8, 3-month follow-up
Self-compassion Scale
Baseline, Week 8, Follow-Up 3 Months
Psychological Flexibility for Body Image
Baseline, Week 8, Follow-Up 3 Months
Forms of Self-criticizing/Attacking and Self-reassuring Scale
Baseline, Week 8, Follow-Up 3 Months
Other Outcomes (2)
Emotion Recognition Task
Baseline and Follow-Up 3 Months
Emotional Stroop task
Baseline and Follow-Up 3 Months
Study Arms (2)
Control group
NO INTERVENTIONParticipants who present significant Body Dysmorphia Symptomatology, as assessed during the screening stage (n ≥ 8) not subjected to any clinical psychology intervention during the period of the current trial. Participants in this group will be assessed at baseline, post-intervention \[immediately after session 8\], and at the 3-month follow-up. They will also be asked to monitor their weekly symptoms through a short self-report assessment.
Intervention group
EXPERIMENTALParticipants who present significant Body Dysmorphia Symptomatology, as assessed during the screening stage (n ≥ 8) subjected to an online manualized group psychological intervention - Mind-over-Mirror. This group will be assessed at baseline, post-intervention \[immediately after session 8\], and at the 3-month follow-up). They will also be asked to monitor their weekly symptoms through a short self-report assessment.
Interventions
An eight session (plus one follow-up booster session) on Acceptance and Commitment Therapy (ACT) with compassion developed specifically for BDD, in a group setting and applied remotely or in hybrid format.
Eligibility Criteria
You may qualify if:
- Aged between 18-65 years;
- Fluent Portuguese speakers;
- Over the cut-off score for the AAI (≥ 21) and the DCQ (≥ 9);
You may not qualify if:
- Pregnant;
- If medicated, not stabilized for at least 2 months
- Currently under other clinical psychology intervention;
- Current suicidal ideation;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CINEICC, Faculty of Psychology and Educational Sciences of the University of Coimbra
Coimbra, Coimbra District, 3000-115, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Coimbra, MSc
CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
- PRINCIPAL INVESTIGATOR
Cláudia Ferreira, PhD
CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
- PRINCIPAL INVESTIGATOR
Ana Ganho-Ávila, Ph.D.
CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychologist; PhD Fellow
Study Record Dates
First Submitted
June 16, 2025
First Posted
June 25, 2025
Study Start
January 29, 2025
Primary Completion
January 30, 2026
Study Completion
January 30, 2026
Last Updated
June 29, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared in order to protect participant confidentiality and in accordance with data protection regulations.